Angiogenesis

During tumor angiogenesis, cancer cells stimulate formation of new blood vessel for delivering oxygen and nutrients to a tumor. As the tumor grows, cells at the center of the mass become starved of oxygen, causing hypoxia. It stabilizes the expression of a transcription factor, HIF-1α (hypoxia inducible factor-1), which binds HIF-1β to upregulate the expression of several angiogenesis-promoting genes. Moreover, growth factor signaling also stimulates HIF-1 activity in order to maintain oxygen homeostasis for growing cells.
-
A8668 Thrombin Receptor Agonist PeptideSummary: Protease-activated receptor agonist -
A4506 DMOGTarget: Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs)Summary: Competitive HIF-PH inhibitor, cell-permeable -
A8636 RN486Summary: Btk inhibitor,potent and selective -
A8661 MNSSummary: Inhibitor of Src/Syk tyrosine kinases -
A8667 AY-NH2Summary: Selective PAR4 agonist -
A8660 Cilengitide1 CitationTarget: IntegrinsSummary: Integrin inhibitor for αvβ3 and αvβ5 -
A8666 TFLLR-NH2Summary: PAR1 selective agonist -
A4189 IOX2(Glycine)1 CitationSummary: HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor -
A3302 CGI-17461 CitationTarget: BTKSummary: Btk inhibitor -
A8665 SLIGRL-NH2Summary: PAR2 activator
